Min-Gi Kmd Jo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Min-Gi Kmd Jo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Byung-Kwan Seo
Department of Acupuncture and Moxibustion, Kyung Hee University College of Korean Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea
1 shared publication Eun-Jung Kmd Kim
Department of Acupuncture & Moxibustion, Dongguk University Bundang Oriental Hospital, Seongnam-si, Republic of Korea
1 shared publication- Geun-Woo Kim
Korean Medicine Doctor, Department of Neuropsychiatry, Dongguk University Bundang Oriental Hospital
1 shared publication - In Suh Kmd Choi
College of Korean Medicine, Kyung Hee University Graduate School, Seoul, Republic of Korea
1 shared publication - Jeong-Hyun Kmd Moon
College of Korean Medicine, Dongguk University Graduate School, Seoul, Republic of Korea
1 shared publication Jung-Hyun Kmd Kim
Department of Acupuncture and Moxibustion Medicine, Kyung Hee University Korean Medicine Hospital at Gangdong, Seoul, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31456
Efficacy and safety evaluation of adjuvant auricular acupuncture for smoking cessation: A study protocol of randomized, assessor-blinded, pragmatic pilot trial
Background: Smoking negatively impacts public health. There are several treatments to quit smoking, and nicotine replacement treatment (NRT) reportedly doubles the smoking cessation rate, with some limitations. Acupuncture is an alternative option with proven effects on smoking cessation. However, there has been no definite report that indicates the efficacy and safety of auricular acupuncture (AA) combined with NRT on smoking cessation. Methods: This is a randomized, assessor-blind, and pragmatic pilot study. We will recruit 40 participants who want to stop smoking and randomly allocate them into an NRT group and an NRT + AA group with a 1:1 ratio. Participants will receive NRT for 4 weeks and the NRT + AA group will receive additional AA treatment with 5 AA points (Shenmen (TF4), lung (CO14), throat (TF3), inner nose (TG4), and endocrine (CO18)) twice a week for 4 weeks. Follow-up will be conducted 1 and 3 months after intervention completion. The primary outcome will be tobacco consumption and abstinence rate determined by calculating the rate of change in cigarette use and a urine test. Secondary outcomes will be the quality of life (EuroQol-5D and visual analogue scale), nicotine dependence (Fagerstrom test for nicotine dependence), nicotine withdrawal (Minnesota nicotine withdrawal scale), physical effects, satisfaction, and safety measurement (adverse events). Results: We will investigate the efficacy and safety of AA combined with NRT treatment for smoking cessation. Conclusion: Our study will provide additional clinical evidence for AA as an adjuvant treatment for smoking cessation. Trial registration number: Clinical Research Information Service (registration number: KCT0007212).
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31456
Open AccessEfficacy and safety evaluation of adjuvant auricular acupuncture for smoking cessation: A study protocol of randomized, assessor-blinded, pragmatic pilot trial
Background: Smoking negatively impacts public health. There are several treatments to quit smoking, and nicotine replacement treatment (NRT) reportedly doubles the smoking cessation rate, with some limitations. Acupuncture is an alternative option with proven effects on smoking cessation. However, there has been no definite report that indicates the efficacy and safety of auricular acupuncture (AA) combined with NRT on smoking cessation. Methods: This is a randomized, assessor-blind, and pragmatic pilot study. We will recruit 40 participants who want to stop smoking and randomly allocate them into an NRT group and an NRT + AA group with a 1:1 ratio. Participants will receive NRT for 4 weeks and the NRT + AA group will receive additional AA treatment with 5 AA points (Shenmen (TF4), lung (CO14), throat (TF3), inner nose (TG4), and endocrine (CO18)) twice a week for 4 weeks. Follow-up will be conducted 1 and 3 months after intervention completion. The primary outcome will be tobacco consumption and abstinence rate determined by calculating the rate of change in cigarette use and a urine test. Secondary outcomes will be the quality of life (EuroQol-5D and visual analogue scale), nicotine dependence (Fagerstrom test for nicotine dependence), nicotine withdrawal (Minnesota nicotine withdrawal scale), physical effects, satisfaction, and safety measurement (adverse events). Results: We will investigate the efficacy and safety of AA combined with NRT treatment for smoking cessation. Conclusion: Our study will provide additional clinical evidence for AA as an adjuvant treatment for smoking cessation. Trial registration number: Clinical Research Information Service (registration number: KCT0007212).